|
1-Methyl-4-phenylpyridinium
|
D015655 |
[An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.
] |
|
Respiratory Mechanics
|
D015656 |
[The physical or mechanical action of the LUNGS; DIAPHRAGM; RIBS; and CHEST WALL during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc.
] |
|
Cystectomy
|
D015653 |
[Used for excision of the urinary bladder.
] |
|
Herpesvirus 6, Human
|
D015654 |
[Strain of HHV-6 VIRUS that is commonly seen in patients affected by MULTIPLE SCLEROSIS and other neurological diseases.
, Strain of HHV-6 VIRUS that primarily occurs in infants and causes a rash and fever. This strand is also common in transplant patients.
, Members of the ROSEOLOVIRUS genus of the Betaherpesvirales subfamily isolated from patients with AIDS and other LYMPHOPROLIFERATIVE DISORDERS. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter the activity of NK CELLS. HHV-6; (HBLV) antibodies are elevated in patients with AIDS; SJOGREN'S SYNDROME; SARCOIDOSIS; CHRONIC FATIGUE SYNDROME, and certain malignancies. HHV-6A is the most common cause of EXANTHEMA SUBITUM and has been implicated in encephalitis. When HHV-6 integrates into the host genome it is referred to as ciHVH-6. When such VIRUS INTEGRATION occurs into the germline it is referred to as iciHHV-6.
] |
|
Aotus trivirgatus
|
D001029 |
[A species in the family AOTIDAE, inhabiting the forested regions of Central and South America (from Panama to the Amazon). Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys.
] |
|
Melibiose
|
D09.698.629.305.540 |
|
|
Aortography
|
D001027 |
[Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures.
] |
|
Mendelevium
|
D01.496.749.305.100.525 |
|
|
Aortopulmonary Septal Defect
|
D001028 |
[A developmental abnormality in which the spiral (aortopulmonary) septum failed to completely divide the TRUNCUS ARTERIOSUS into ASCENDING AORTA and PULMONARY ARTERY. This abnormal communication between the two major vessels usually lies above their respective valves (AORTIC VALVE; PULMONARY VALVE).
] |
|
Acupuncture Therapy
|
D015670 |
[Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. It is sometimes used in conjunction with heat, moxibustion, acupressure, or electric stimulation.
] |
|
Lemur
|
B01.050.150.900.649.313.988.700.508.490 |
|
|
Lemuridae
|
B01.050.150.900.649.313.988.700.508 |
|
|
Carcinoma 256, Walker
|
C04.557.435.290.210 |
|
|
Carcinosarcoma
|
C04.557.435.290 |
|
|
Aortic Valve
|
D001021 |
[The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.
] |
|
Protective Factors
|
E05.318.740.600.800.582 |
|
|
Aortic Valve Insufficiency
|
D001022 |
[Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).
] |
|
Aortic Stenosis, Subvalvular
|
D001020 |
[A pathological constriction occurring in the region below the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
] |
|
Nevada
|
Z01.107.567.875.760.550 |
|
|
Aortitis
|
D001025 |
[Inflammation of the wall of the AORTA.
] |
